EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 Cases

Vanesa-Sindi Ivanova, Visar Vela, Stefan Dirnhofer, Michael Dobbie, Frank Stenner, Jan Knoblich, Alexandar Tzankov, Thomas Menter

Pathobiology · 2024

DOI: 10.1159/000535938 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pathobiology, 2024. Verfasst von Vanesa-Sindi Ivanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland, vanesa-sindiivelinova.iva…. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, In Situ Hybridization, Fluorescence, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity. Lately, several algorithms achieving therapeutically and prognostically relevant DLBCL subclassification have been published.

Methods

A cohort of 74 routine DLBCL cases was broadly characterized by immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) of the BCL2, BCL6, and MYC loci, and comprehensive high-throughput sequencing (HTS). Based on the genetic alterations found, cases were reclassified using two probabilistic tools – LymphGen and Two-step classifier, allowing for comparison of the two models.

Results

Hans and Tally’s overall IHC-based subclassification success rate was 96% and 82%, respectively. HTS and FISH data allowed the LymphGen algorithm to successfully classify 11/55 cases (1 – BN2, 7 – EZB, 1 – MCD, and 2 – genetically composite EZB/N1). The total subclassification rate was 20%. On the other hand, the Two-step classifier categorized 36/55 cases, with 65.5% success (9 – BN2, 12 – EZB, 9 – MCD, 2 – N1, and 4 – ST2). Clinical correlations highlighted MCD as an aggressive subtype associated with higher relapse and mortality.

Conclusions

The Two-step algorithm has a better success rate at subclassifying DLBCL cases based on genetic differences. Further improvement of the classifiers is required to increase the number of classifiable cases and thus prove their applicability in routine diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseIn Situ Hybridization, FluorescenceHigh-Throughput Nucleotide SequencingHumansMaleFemaleMiddle AgedAgedAdultImmunohistochemistryProto-Oncogene Proteins c-bcl-2Aged, 80 and overAlgorithmsProto-Oncogene Proteins c-bcl-6Biomarkers, TumorCohort StudiesPrognosisProto-Oncogene Proteins c-myc

Stichwörter der Autor:innen

Cell of originDiffuse large B-cell lymphomaGenetic subclassificationHigh-throughput sequencingMYD88

Substanzen

Proto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6BCL2 protein, humanBCL6 protein, humanBiomarkers, TumorProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland, vanesa-sindiivelinova.ivanova@usb.ch.
  • Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Department of Oncology, Hôpital du Jura, Delemont, Switzerland.
  • Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Onkologie Dreilaendereck, Loerrach, Germany.

Zitieren

APA

Ivanova, V. S., Vela, V., Dirnhofer, S., Dobbie, M., Stenner, F., Knoblich, J., Tzankov, A., & Menter, T. (2024). Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 Cases. Pathobiology. https://doi.org/10.1159/000535938

Vancouver

Ivanova VS, Vela V, Dirnhofer S, Dobbie M, Stenner F, Knoblich J, et al. Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 Cases. Pathobiology. 2024. doi:10.1159/000535938

BibTeX
@article{Ivanova2024,
  author = {Ivanova, Vanesa-Sindi and Vela, Visar and Dirnhofer, Stefan and Dobbie, Michael and Stenner, Frank and Knoblich, Jan and Tzankov, Alexandar and Menter, Thomas},
  title = {Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 Cases},
  journal = {Pathobiology},
  year = {2024},
  doi = {10.1159/000535938}
}
Kostenlos starten →